Treatment of -mutated advanced or metastatic melanoma: rationale, current trials and evidence to date

by Amélie Boespflug, Julie Caramel, Stephane Dalle, Luc Thomas
Published 2017-07-01

Decreased survival in patients treated by chemotherapy after targeted therapy compared to immunotherapy in metastatic melanoma

by Marie‐Alix Mangin, Amélie Boespflug, Delphine Maucort Boulch, Charles‐Hervé Vacheron, Isabelle Carpentier, Luc Thomas, Stéphane Dalle
Published 2021-05-01

Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes

by Charline Lafayolle de la Bruyère, Pierre-Jean Souquet, Stéphane Dalle, Pauline Corbaux, Amélie Boespflug, Michaël Duruisseaux, Lize Kiakouama-Maleka, Thibaut Reverdy, Madeleine Maugeais, Gulsum Sahin, Denis Maillet, Julien Péron
Published 2021-05-01

Seven Non-melanoma Features to Rule Out Facial Melanoma

by Philipp Tschandl, Alessio Gambardella, Amélie Boespflug, Teresa Deinlein, Vincenzo de Giorgi, Harald Kittler, Aimilios Lallas, Josep Malvehy, Elvira Moscarella, Susana Puig, Massimiliano Scalvenzi, Luc Thomas, Iris Zalaudek, Roberto Alfano, Giuseppe Argenziano
Published 2017-08-01